大理大学学报 ›› 2026, Vol. 11 ›› Issue (2): 15-21.DOI: 10. 3969 / j. issn. 2096-2266. 2026. 02. 003

• 药学 • 上一篇    下一篇

美洲大蠊提取物CⅡ-3对环磷酰胺诱导的肠道免疫损伤的影响#br#

闫 娜1,吴广俊1,张维炜2,刘晓波1,郭美仙1*   

  1. (1. 大理大学药学院,云南大理 671000;2. 三门县人民医院,浙江台州 317100)
  • 收稿日期:2025-08-20 修回日期:2025-11-22 出版日期:2026-02-15 发布日期:2026-03-18
  • 通讯作者: 郭美仙,高级实验师,E-mail:310547786@qq.com。
  • 作者简介:闫娜,硕士研究生,主要从事药理学研究。
  • 基金资助:
    云南省地方本科高校基础研究联合专项资金项目(202101BA070001-121;202101BA070001-119);云南省兴滇英
    才支持计划团队专项(202305AS350001);云南省昆虫生物医药研发重点实验室开放课题(AT2024002)

Effects of Periplaneta americana Extract CⅡ-3 on Cyclophosphamide-Induced Intestinal Immune Injury

Yan Na1, Wu Guangjun1, Zhang Weiwei2, Liu Xiaobo1, Guo Meixian1*   

  1. (1. College of Pharmacy, Dali University, Dali, Yunnan 671000, China; 2. Sanmen County People′s Hospital, Taizhou, Zhejiang
    317100, China)
  • Received:2025-08-20 Revised:2025-11-22 Online:2026-02-15 Published:2026-03-18

摘要: 目的:探索美洲大蠊提取物CⅡ-3对环磷酰胺诱导的肠道免疫损伤的影响。方法:将40只Balb/c小鼠随机分为正常
组、模型组及CⅡ-3低、中、高剂量组(25、50、100 mg/kg)。除正常组外,其余各组连续3 d腹腔注射40 mg/kg环磷酰胺建立肠道
免疫损伤模型,自第4天起,各给药组灌胃相应剂量CⅡ-3,正常组和模型组给予0.9%氯化钠溶液,持续14 d。检测粪便含水
率、派伊尔结(PPs)数量及肠道IgA、IgM、sIgA含量;通过苏木精-伊红染色观察组织形态,实时荧光定量PCR检测相关基因
mRNA表达水平。结果:环磷酰胺显著降低粪便含水率、PPs数量及IgA、IgM、sIgA水平,并造成肠黏膜结构破坏。CⅡ-3处理
可剂量依赖性提高粪便含水率及IgA、IgM、sIgA水平,增加PPs数量并改善组织损伤;CⅡ-3中、高剂量组可上调T-bet、GATA-
3及Foxp3表达,下调RORγt,恢复Th1/Th2与Th17/Treg平衡;CⅡ-3高剂量组显著上调Occludin、Claudin-1和Zo-1表达,改善
肠道物理屏障功能。结论:CⅡ-3可通过调节肠道免疫细胞平衡、促进抗体生成及增强紧密连接蛋白表达,改善环磷酰胺诱导
的肠道损伤并增强黏膜免疫功能,为其作为肠道免疫损伤干预材料提供理论依据。

关键词: 美洲大蠊, CⅡ-3, 环磷酰胺, 肠道免疫, 紧密连接蛋白

Abstract: Objective: To investigate the effects of Periplaneta americana extract CⅡ-3 on cyclophosphamide-induced intestinal
immune injury. Methods: Forty Balb/c mice were randomly divided into a normal group, a model group, and low-, medium-, and
high-dose CⅡ-3 groups (25, 50, and 100 mg/kg). Except for the normal group, all mice received intraperitoneal injections of
cyclophosphamide (40 mg/kg) for three consecutive days to establish the model. From day 4, mice in the treatment groups were administered
CⅡ-3 by gavage for 14 days, while the normal and model groups received 0.9% sodium chloride solution. Fecal water content, Peyer′s
patches (PPs) numbers, and intestinal IgA, IgM, and sIgA levels were measured. Histopathological changes were evaluated by
hematoxylin-eosin staining, and mRNA expression of immune-related genes was detected by real-time quantitative PCR. Results: Cyclophos⁃
phamide significantly reduced fecal water content, PPs numbers, and IgA, IgM, and sIgA levels, and caused intestinal mucosal damage.
CⅡ-3 treatment dose-dependently increased fecal water content and immunoglobulin levels, elevated PPs numbers, and alleviated
histological injury. Medium- and high-dose CⅡ-3 upregulated T-bet, GATA-3, and Foxp3 expression while downregulating RORγt,
thereby restoring Th1/Th2 and Th17/Treg balance. High-dose CⅡ-3 significantly increased the expression of Occludin, Claudin-1,
and Zo-1, improving intestinal barrier function. Conclusion: CⅡ-3 ameliorates cyclophosphamide-induced intestinal injury and
enhances mucosal immune function by regulating immune cell balance, promoting antibody production, and enhancing tight junction
protein expression, providing a theoretical basis for its application in intestinal immune injury intervention.

Key words: Periplaneta americana, CⅡ-3, cyclophosphamide, intestinal immunity, tight junction protein

中图分类号: